"Radiobiology of Proton Therapy": Results of an international expert workshop

被引:89
作者
Luehr, Armin [1 ,2 ,3 ,4 ,5 ]
von Neubeck, Claere [2 ,3 ,4 ,5 ]
Pawelke, Joerg [1 ,2 ,3 ]
Seidlitz, Annekatrin [2 ,3 ,4 ,5 ,6 ,7 ]
Peitzsch, Claudia [2 ,3 ,4 ,5 ,7 ,8 ,9 ,10 ]
Bentzen, Soren M. [11 ,12 ]
Bortfeld, Thomas [13 ]
Debus, Juergen [5 ,14 ,15 ]
Deutsch, Eric [16 ,17 ]
Langendijk, Johannes A. [18 ]
Loeffler, Jay S. [19 ,20 ,21 ]
Mohan, Radhe [22 ]
Scholz, Michael [23 ]
Sorensen, Brita S. [24 ]
Weber, Damien C. [25 ]
Baumann, Michael [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
Krause, Mechthild [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] Helmholtz Zentrum Dresden Rossendorf, Inst Radiooncol OncoRay, Dresden, Germany
[2] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany
[3] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Univ Hosp Carl Gustav Carus, Dresden, Germany
[4] German Canc Consortium DKTK, Partner Site Dresden, Heidelberg, Germany
[5] German Canc Res Ctr, Heidelberg, Germany
[6] Tech Univ Dresden, Fac Med, Dept Radiotherapy & Radiat Oncol, Dresden, Germany
[7] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
[8] Natl Ctr Tumor Dis NCT, Partner Site Dresden, Dresden, Germany
[9] Tech Univ Dresden, Fac Med, Dresden, Germany
[10] HZDR, Helmholtz Assoc, Dresden, Germany
[11] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Div Biostat & Bioinformat, Baltimore, MD 21201 USA
[12] Univ Maryland, Sch Med, Dept Radiat Oncol, Maryland Proton Therapy Ctr, Baltimore, MD 21201 USA
[13] Massachusetts Gen Hosp, Dept Radiat Oncol, Div Phys, Boston, MA 02114 USA
[14] Univ Heidelberg German Consortium Translat Oncol, Dept Radiat Oncol, Heidelberg, Germany
[15] Natl Ctr Tumor Dis NCT, Heidelberg, Germany
[16] INSERM, Dept Radiat Oncol, Gustave Roussy Canc Campus, F-1030 Villejuif, France
[17] Univ Paris Sud, Fac Med Kremlin Bicetre Paris Sud, Le Kremlin Bicetre, France
[18] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands
[19] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA
[20] Harvard Med Sch, Boston, MA USA
[21] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA
[22] UT MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX USA
[23] GSI Helmholtz Ctr Heavy Ion Res, Dept Biophys, Darmstadt, Germany
[24] Aarhus Univ Hosp, Dept Expt Clin Oncol, Aarhus, Denmark
[25] Paul Scherrer Inst, ETH Domain, Ctr Proton Therapy, Villigen, Switzerland
关键词
Relative biological effectiveness (RBE); Proton beam therapy; Radiobiology; Treatment planning; Trial design; RELATIVE BIOLOGICAL EFFECTIVENESS; MODEL-BASED APPROACH; BEAM THERAPY; CONCURRENT CHEMOTHERAPY; CANCER-PATIENTS; NECK-CANCER; RADIATION-THERAPY; PARTICLE THERAPY; TREATMENT PLANS; ADVANCED HEAD;
D O I
10.1016/j.radonc.2018.05.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The physical properties of proton beams offer the potential to reduce toxicity in tumor-adjacent normal tissues. Toward this end, the number of proton radiotherapy facilities has steeply increased over the last 10-15 years to currently around 70 operational centers worldwide. However, taking full advantage of the opportunities offered by proton radiation for clinical radiotherapy requires a better understanding of the radiobiological effects of protons alone or combined with drugs or immunotherapy on normal tissues and tumors. This report summarizes the main results of the international expert workshop "Radiobiology of Proton Therapy" that was held in November 2016 in Dresden. It addresses the major topics (1) relative biological effectiveness (RBE) in proton beam therapy, (2) interaction of proton radiobiology with radiation physics in current treatment planning, (3) biological effects in proton therapy combined with systemic treatments, and (4) testing biological effects of protons in clinical trials. Finally, important research avenues for improvement of proton radiotherapy based on radiobiological knowledge are identified. The clinical distribution of radiobiological effectiveness of protons alone or in combination with systemic chemo-or immunotherapies as well as patient stratification based on biomarker expressions are key to reach the full potential of proton beam therapy. Dedicated preclinical experiments, innovative clinical trial designs, and large high-quality data repositories will be most important to achieve this goal. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:56 / 67
页数:12
相关论文
共 88 条
[1]  
Wambersie Andre, 2007, J ICRU, V7, P1, DOI [10.1093/jicru/ndm014, 10.1093/jicru/ndm003]
[2]   The impact of treatment accuracy on proton therapy patient selection for oropharyngeal cancer patients [J].
Arts, Tine ;
Breedveld, Sebastiaan ;
de Jong, Martin A. ;
Astreinidou, Eleftheria ;
Tans, Lisa ;
Keskin-Cambay, Fatma ;
Krol, Augustinus D. G. ;
van de Water, Steven ;
Bijman, Rik G. ;
Hoogeman, Mischa S. .
RADIOTHERAPY AND ONCOLOGY, 2017, 125 (03) :520-525
[3]   Survival of tumor cells after proton irradiation with ultra-high dose rates [J].
Auer, Susanne ;
Hable, Volker ;
Greubel, Christoph ;
Drexler, Guido A. ;
Schmid, Thomas E. ;
Belka, Claus ;
Dollinger, Guenther ;
Friedl, Anna A. .
RADIATION ONCOLOGY, 2011, 6
[4]   LET-painting increases tumour control probability in hypoxic tumours [J].
Bassler, Niels ;
Toftegaard, Jakob ;
Luehr, Armin ;
Sorensen, Brita Singers ;
Scifoni, Emanuele ;
Kraemer, Michael ;
Jaekel, Oliver ;
Mortensen, Lise Sakso ;
Overgaard, Jens ;
Petersen, Jorgen B. .
ACTA ONCOLOGICA, 2014, 53 (01) :25-32
[5]   Radiation oncology in the era of precision medicine [J].
Baumann, Michael ;
Krause, Mechthild ;
Overgaard, Jens ;
Debus, Juergen ;
Bentzen, Soren M. ;
Daartz, Juliane ;
Richter, Christian ;
Zips, Daniel ;
Bortfeld, Thomas .
NATURE REVIEWS CANCER, 2016, 16 (04) :234-249
[6]   Randomized controlled trials in health technology assessment: Overkill or overdue? [J].
Bentzen, Soren M. .
RADIOTHERAPY AND ONCOLOGY, 2008, 86 (02) :142-147
[7]   Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy [J].
Bijman, Rik G. ;
Breedveld, Sebastiaan ;
Arts, Tine ;
Astreinidou, Eleftheria ;
de Jong, Martin A. ;
Granton, Patrick V. ;
Petit, Steven F. ;
Hoogeman, Mischa S. .
ACTA ONCOLOGICA, 2017, 56 (11) :1444-1450
[8]   Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis [J].
Blanchard, Pierre ;
Garden, Adam S. ;
Gunn, G. Brandon ;
Rosenthal, David I. ;
Morrison, William H. ;
Hernandez, Mike ;
Crutison, Joseph ;
Lee, Jack J. ;
Ye, Rong ;
Fuller, C. David ;
Mohamed, Abdallah S. R. ;
Hutcheson, Kate A. ;
Holliday, Emma B. ;
Thaker, Nikhil G. ;
Sturgis, Erich M. ;
Kies, Merrill S. ;
Zhu, X. Ronald ;
Mohan, Radhe ;
Frank, Steven J. .
RADIOTHERAPY AND ONCOLOGY, 2016, 120 (01) :48-55
[9]   Investigating the robustness of ion beam therapy treatment plans to uncertainties in biological treatment parameters [J].
Boehlen, T. T. ;
Brons, S. ;
Dosanjh, M. ;
Ferrari, A. ;
Fossati, P. ;
Haberer, T. ;
Patera, V. ;
Mairani, A. .
PHYSICS IN MEDICINE AND BIOLOGY, 2012, 57 (23) :7983-8004
[10]   Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study [J].
Bradley, Jeffrey D. ;
Paulus, Rebecca ;
Komaki, Ritsuko ;
Masters, Gregory ;
Blumenschein, George ;
Schild, Steven ;
Bogart, Jeffrey ;
Hu, Chen ;
Forster, Kenneth ;
Magliocco, Anthony ;
Kavadi, Vivek ;
Garces, Yolanda I. ;
Narayan, Samir ;
Iyengar, Puneeth ;
Robinson, Cliff ;
Wynn, Raymond B. ;
Koprowski, Christopher ;
Meng, Joanne ;
Beitler, Jonathan ;
Gaur, Rakesh ;
Curran, Walter, Jr. ;
Choy, Hak .
LANCET ONCOLOGY, 2015, 16 (02) :187-199